Dipyridamole suppresses high glucose-induced osteopontin secretion and mRNA expression in rat aortic smooth muscle cells

Circulation Journal

Volumn 74, Issue 6, 2010, Pages 1242-1250

  Hsieh, Ming Song ^c   Zhong, Wen Bin ^b   Yu, Shu Chuan ^a   Lin, John Yi Chuan ^a   Chi, Wei Ming ^a   Lee, Horng Mo ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b School of Chinese Medicine   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Dipyridamole; High glucose; Signal transduction

Indexed keywords

ACETYLCYSTEINE; CYCLIC AMP; CYCLIC GMP; DIPYRIDAMOLE; GLUCOSE; MESSENGER RNA; OSTEOPONTIN; PHOSPHODIESTERASE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENZYME INHIBITION; GENE EXPRESSION; NONHUMAN; PROTEIN INDUCTION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; ANTIOXIDANTS; AORTA; BIOLOGICAL MARKERS; CALCINOSIS; CELLS, CULTURED; DIABETIC ANGIOPATHIES; DIPYRIDAMOLE; GLUCOSE; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; PHOSPHODIESTERASE INHIBITORS; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 77953493495     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0561     Document Type: Article

References (29)

1. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860-864.
2. Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, et al. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention. Circ J 2009; 73: 152-157.
3. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393-2402.
4. Mori S, Yasuda S, Kataoka Y, Morii I, Kawamura A, Miyazaki S. Significant association of coronary artery calcification in stent delivery route with restenosis after sirolimus-eluting stent implantation. Circ J 2009; 73: 1856-1863.
5. Ueeda M, Doumei T, Takaya Y, Shinohata R, Katayama Y, Ohnishi N, et al. Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circ J 2008; 72: 1836-1843.
6. Fujiu A, Ogawa T, Matsuda N, Ando Y, Nitta K. Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction in chronic hemodialysis patients. Circ J 2008; 72: 1768-1772.
7. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998; 101: 1468-1478.
8. Senger DR, Perruzzi CA, Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 1989; 9: 1291-1300.
9. Tamada S, Nakatani T, Asai T, Tashiro K, Komiya T, Sumi T, et al. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int 2003; 63: 306-314.
10. Beavo JA. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
11. Hammond JR, Williams EF, Clanachan AS. Affinity of calcium channel inhibitors, benzodiazepines, and other vasoactive compounds for the nucleoside transport system. Can J Physiol Pharmacol 1985; 63: 1302-1307.
12. Stafford NP, Pink AE, White AE, Glenn JR, Heptinstall S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003; 23: 1928-1933.
13. Dubey RK, Gillespie DG, Jackson EK. Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells. Hypertension 1999; 33: 190-194.
14. Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, et al. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis. Kidney Int 1999; 56: 932-943.
15. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 624-628.
16. Kawamura H, Yokote K, Asaumi S, Kobayashi K, Fujimoto M, Maezawa Y, et al. High glucose-induced upregulation of osteopon-tin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24: 276-281.
17. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696.
18. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993; 73: 193-204.
19. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 1993; 13: 120-125.
20. Wang X, Louden C, Ohlstein EH, Stadel JM, Gu JL, Yue TL. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angio-plasty. Arterioscler Thromb Vasc Biol 1996; 16: 1365-1372.
21. Majack RA, Milbrandt J, Dixit VM. Induction of thrombospondin messenger RNA levels occurs as an immediate early response to platelet derived growth factor. J Biol Chem 1987; 262: 8821-8825.
22. Majesky MW. Neointima formation after acute vascular injury: Role of counteradhesive extracellular matrix proteins. Tex Heart Inst J 1994; 21: 78-85.
23. Dey NB, Boerth NJ, Murphy-Ullrich JE, Chang PL, Prince CW, Lincoln TM. Cyclic GMP-dependent protein kinase inhibits osteo-pontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 1998; 82: 139-146.
24. Zhuplatov SB, Masaki T, Blumenthal DK, Cheung AK. Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation. Basic Clin Pharmacol Toxicol 2006; 99: 431-439.
25. Andoh T, Chiueh CC, Chock PB. Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin per-oxidase-1 during hormesis in response to oxidative stress-induced apoptosis. J Biol Chem 2003; 278: 885-890.
26. Scatena M, Liaw L, Giachelli CM. Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
27. Lee SH, Li C, Lim SW, Ahn KO, Choi BS, Kim YS, et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol 2005; 25: 64-76.
28. Li C, Sun BK, Lim SW, Song JC, Kang SW, KimYS, et al. Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy. Transplantation 2005; 79: 1522-1529.
29. O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, et al. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals. Cells Tissues Organs 2009; 189: 51-55.